Radiation therapy for stage I lung cancer detected on computed tomography screening: results from the international early lung cancer action program. Journal of Radiation Oncology 2014; 3:153- 157.Michael, BucksteinRowena, YipDavid F., YankelevitzClaudia I., HenschkeKenneth, Rosenzweig. (2014) ...
Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-small Cell Lung Cancer (NSCLC): Analysis Based on the New TNM Classification and Difference Due to HistologyNeoplasms of the oral cavitypostoperative radiation therapyconcurrent chemotherapySuicide gene therapy has become an effective therapy for...
Lung Cancer Volume 7, Issue 3, June 1991, Pages 208Abstract radiotherapyRadiation therapy for medically inoperable stage I and II non-small cell lung cancer : Armstrong JG, Minksy BD. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 1002...
Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies Because of difficulties with stabilization, breathing motion and dosimetry, stereotactic body radiotherapy for lung cancer has only been practiced for the ... H Onishi,T Araki - 《...
To compare 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable early-stage lung cancer to determine which produces the lowest rate of grade 鈮 3 protocol-specified adverse events (psAEs) at 1year. Patients with... GM Videtic,C Hu,AK Singh,... - 《Int J Radiat...
Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who's down for the count? Surgery versus stereotactic body radiation therapy for early stage lung cancer: who's down for the count? J Clin Oncol 2010;28:907-8.Timmerman, R. D. Surgery versus stereotactic body rad...
Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236 Fakiris A, Bezjak A, Videtic G, Choy H: Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG ... - 《International Journal...
Stereotactic Body Radiation Therapy for Stage I Non–Small Cell Lung Cancer Conventional fractionated radiotherapy has resulted in 5-year local control rates of 30% to 50% and overall survival rates of 10% to 30% in stage I inopera... Joe,Y.,Chang,... - 《Thoracic Surgery Clinics》 被引...
PD-0279 VALUE OF 18F-FDG-PET/CT AFTER STEREOTACTIC BODY RADIATION THERAPY FOR STAGE I NON-SMALL CELL LUNG CANCER Purpose: To evaluate the diagnostic value of positron-emission tomography/computed tomography (PET/CT) in stage I lung cancer patients treated with stereotactic body radiation therapy ...
The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer Purpose Stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer (NSCLC) offers excellent control rates. Most pu......